Regina Berger

3.3k total citations
28 papers, 445 citations indexed

About

Regina Berger is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Regina Berger has authored 28 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Reproductive Medicine and 9 papers in Molecular Biology. Recurrent topics in Regina Berger's work include Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (4 papers). Regina Berger is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (4 papers). Regina Berger collaborates with scholars based in Austria, Germany and Belgium. Regina Berger's co-authors include Heidi Fiegl, Markus W. Hollmann, Philipp Lirk, Hans H. Goebel, Elisabeth Müller‐Holzner, Allison Jones, Daniel Egle, Martin Widschwendter, Daniel Reimer and Dirk Eick and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Regina Berger

28 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Regina Berger Austria 10 171 124 94 84 75 28 445
Lara Paracchini Italy 10 220 1.3× 138 1.1× 63 0.7× 64 0.8× 167 2.2× 17 537
Wen‐Ning Fang China 7 211 1.2× 54 0.4× 87 0.9× 36 0.4× 85 1.1× 8 403
Leszek Noga Poland 14 129 0.8× 75 0.6× 111 1.2× 24 0.3× 53 0.7× 30 450
Hugo Gass Argentina 10 88 0.5× 204 1.6× 55 0.6× 38 0.5× 59 0.8× 14 342
Yihang Shen China 12 258 1.5× 74 0.6× 66 0.7× 9 0.1× 80 1.1× 32 399
Ishan Roy United States 8 135 0.8× 217 1.8× 143 1.5× 20 0.2× 30 0.4× 23 387
Diyuan Qin China 11 164 1.0× 313 2.5× 197 2.1× 63 0.8× 52 0.7× 27 548
Johji Inazawa Japan 10 308 1.8× 34 0.3× 50 0.5× 10 0.1× 47 0.6× 16 452

Countries citing papers authored by Regina Berger

Since Specialization
Citations

This map shows the geographic impact of Regina Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Berger more than expected).

Fields of papers citing papers by Regina Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Berger. The network helps show where Regina Berger may publish in the future.

Co-authorship network of co-authors of Regina Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Regina Berger. A scholar is included among the top collaborators of Regina Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina Berger. Regina Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Andrews, John, et al.. (2023). Patient involvement in research within the Gynecological Cancer InterGroup: A call to action for a systematic approach: Results from a survey. Health Science Reports. 6(12). e1735–e1735. 1 indexed citations
3.
4.
Polterauer, Stephan, Olaf Reich, Andreas Widschwendter, et al.. (2022). Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial. Gynecologic Oncology. 165(1). 23–29. 21 indexed citations
5.
Labidi‐Galy, Sana Intidhar, Manuel Rodrigues, José Luís Sandoval, et al.. (2022). Efficacy of maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced ovarian cancer according to BRCA mutation genotype in the phase III PAOLA-1/ENGOT-ov25 trial.. Journal of Clinical Oncology. 40(16_suppl). 5571–5571. 2 indexed citations
6.
7.
8.
Alavi, Sara, Rolf Richter, Maren Keller, et al.. (2020). Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV). International Journal of Gynecological Cancer. 30(4). 509–514. 10 indexed citations
9.
Polterauer, Stephan, Olaf Reich, Andreas Widschwendter, et al.. (2019). P39 ITIC2 trial – topical imiquimod versus conization to treat cervical intraepithelial neoplasia: randomised controlled, non-inferiority trial. A73–A74. 1 indexed citations
10.
11.
12.
13.
14.
Ratzinger, Gudrun, Regina Berger, Bernhard Zelger, et al.. (2014). Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients. International Journal of Molecular Sciences. 15(7). 11984–11995. 8 indexed citations
15.
Hofstetter, Gerda, Astrid Berger, Regina Berger, et al.. (2012). The N-Terminally Truncated p53 Isoform △40p53 Influences Prognosis in Mucinous Ovarian Cancer. International Journal of Gynecological Cancer. 22(3). 372–379. 38 indexed citations
16.
Lirk, Philipp, Regina Berger, Markus W. Hollmann, & Heidi Fiegl. (2012). Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. British Journal of Anaesthesia. 109(2). 200–207. 104 indexed citations
17.
Goebel, Hans H., Regina Berger, Alexander Strasak, et al.. (2011). Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients. British Journal of Cancer. 106(1). 189–198. 63 indexed citations
18.
Berger, Regina, Heidi Fiegl, Hans H. Goebel, et al.. (2010). Toll‐like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors. Cancer Science. 101(4). 1059–1066. 74 indexed citations
19.
Berger, Regina & Martin Diewald. (1987). Living-conditions and their assessment.. Social Indicators Research. 19(1). 137. 2 indexed citations
20.
Andrieu, J, P. Casassus, L Degos, et al.. (1980). Burkitt’s Lymphoma Occurring 6 Years after Hodgkin’s Disease. Acta Haematologica. 63(6). 330–332. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara Paracchini Breakdown of academic impact, for papers by Wen‐Ning Fang Breakdown of academic impact, for papers by Leszek Noga Breakdown of academic impact, for papers by Hugo Gass Breakdown of academic impact, for papers by Yihang Shen Breakdown of academic impact, for papers by Ishan Roy Breakdown of academic impact, for papers by Diyuan Qin Breakdown of academic impact, for papers by Johji Inazawa
Rankless by CCL
2026